These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

295 related articles for article (PubMed ID: 26401945)

  • 1. Distinct Pattern of Gray Matter Atrophy in Mild Alzheimer's Disease Impacts on Cognitive Outcomes of Noninvasive Brain Stimulation.
    Anderkova L; Eliasova I; Marecek R; Janousova E; Rektorova I
    J Alzheimers Dis; 2015; 48(1):251-60. PubMed ID: 26401945
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Non-invasive brain stimulation of the right inferior frontal gyrus may improve attention in early Alzheimer's disease: a pilot study.
    Eliasova I; Anderkova L; Marecek R; Rektorova I
    J Neurol Sci; 2014 Nov; 346(1-2):318-22. PubMed ID: 25216556
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Patterns of Grey Matter Atrophy at Different Stages of Parkinson's and Alzheimer's Diseases and Relation to Cognition.
    Kunst J; Marecek R; Klobusiakova P; Balazova Z; Anderkova L; Nemcova-Elfmarkova N; Rektorova I
    Brain Topogr; 2019 Jan; 32(1):142-160. PubMed ID: 30206799
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Repetitive Transcranial Magnetic Stimulation as an Alternative Therapy for Cognitive Impairment in Alzheimer's Disease: A Meta-Analysis.
    Liao X; Li G; Wang A; Liu T; Feng S; Guo Z; Tang Q; Jin Y; Xing G; McClure MA; Chen H; He B; Liu H; Mu Q
    J Alzheimers Dis; 2015; 48(2):463-72. PubMed ID: 26402010
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Cognition, brain atrophy, and cerebrospinal fluid biomarkers changes from preclinical to dementia stage of Alzheimer's disease and the influence of apolipoprotein e.
    Susanto TA; Pua EP; Zhou J;
    J Alzheimers Dis; 2015; 45(1):253-68. PubMed ID: 25524955
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Magnetization transfer imaging of gray and white matter in mild cognitive impairment and Alzheimer's disease.
    van Es AC; van der Flier WM; Admiraal-Behloul F; Olofsen H; Bollen EL; Middelkoop HA; Weverling-Rijnsburger AW; Westendorp RG; van Buchem MA
    Neurobiol Aging; 2006 Dec; 27(12):1757-62. PubMed ID: 16290268
    [TBL] [Abstract][Full Text] [Related]  

  • 7. High-frequency repetitive transcranial magnetic stimulation combined with cognitive training improves cognitive function and cortical metabolic ratios in Alzheimer's disease.
    Zhang F; Qin Y; Xie L; Zheng C; Huang X; Zhang M
    J Neural Transm (Vienna); 2019 Aug; 126(8):1081-1094. PubMed ID: 31292734
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Gray matter atrophy associated with mild cognitive impairment in Parkinson's disease.
    Chen FX; Kang DZ; Chen FY; Liu Y; Wu G; Li X; Yu LH; Lin YX; Lin ZY
    Neurosci Lett; 2016 Mar; 617():160-5. PubMed ID: 26742642
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Transcranial magnetic stimulation improves naming in Alzheimer disease patients at different stages of cognitive decline.
    Cotelli M; Manenti R; Cappa SF; Zanetti O; Miniussi C
    Eur J Neurol; 2008 Dec; 15(12):1286-92. PubMed ID: 19049544
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Effects of low versus high frequencies of repetitive transcranial magnetic stimulation on cognitive function and cortical excitability in Alzheimer's dementia.
    Ahmed MA; Darwish ES; Khedr EM; El Serogy YM; Ali AM
    J Neurol; 2012 Jan; 259(1):83-92. PubMed ID: 21671144
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Following the Spreading of Brain Structural Changes in Alzheimer's Disease: A Longitudinal, Multimodal MRI Study.
    Weiler M; Agosta F; Canu E; Copetti M; Magnani G; Marcone A; Pagani E; Balthazar ML; Comi G; Falini A; Filippi M
    J Alzheimers Dis; 2015; 47(4):995-1007. PubMed ID: 26401778
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Repetitive transcranial magnetic stimulation for cognitive impairment in Alzheimer's disease: a meta-analysis of randomized controlled trials.
    Wang X; Mao Z; Ling Z; Yu X
    J Neurol; 2020 Mar; 267(3):791-801. PubMed ID: 31760522
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Grey-matter atrophy in Alzheimer's disease is asymmetric but not lateralized.
    Derflinger S; Sorg C; Gaser C; Myers N; Arsic M; Kurz A; Zimmer C; Wohlschläger A; Mühlau M
    J Alzheimers Dis; 2011; 25(2):347-57. PubMed ID: 21422522
    [TBL] [Abstract][Full Text] [Related]  

  • 14. A systematic review and meta-analysis of rTMS effects on cognitive enhancement in mild cognitive impairment and Alzheimer's disease.
    Chou YH; Ton That V; Sundman M
    Neurobiol Aging; 2020 Feb; 86():1-10. PubMed ID: 31783330
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Repetitive transcranial magnetic stimulation (rTMS) combined with cognitive training is a safe and effective modality for the treatment of Alzheimer's disease: clinical experience.
    Rabey JM; Dobronevsky E
    J Neural Transm (Vienna); 2016 Dec; 123(12):1449-1455. PubMed ID: 27631152
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Using voxel-based morphometry to map the structural changes associated with rapid conversion in MCI: a longitudinal MRI study.
    Chételat G; Landeau B; Eustache F; Mézenge F; Viader F; de la Sayette V; Desgranges B; Baron JC
    Neuroimage; 2005 Oct; 27(4):934-46. PubMed ID: 15979341
    [TBL] [Abstract][Full Text] [Related]  

  • 17. The effects of repetitive transcranial magnetic stimulation in older adults with mild cognitive impairment: a protocol for a randomized, controlled three-arm trial.
    Taylor JL; Hambro BC; Strossman ND; Bhatt P; Hernandez B; Ashford JW; Cheng JJ; Iv M; Adamson MM; Lazzeroni LC; McNerney MW
    BMC Neurol; 2019 Dec; 19(1):326. PubMed ID: 31842821
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Different cognitive profiles between mild cognitive impairment due to cerebral small vessel disease and mild cognitive impairment of Alzheimer's disease origin.
    Zhou A; Jia J
    J Int Neuropsychol Soc; 2009 Nov; 15(6):898-905. PubMed ID: 19891819
    [TBL] [Abstract][Full Text] [Related]  

  • 19. [The comparison of the regional cerebral metabolism rate of glucose in Alzheimer's disease with mild cognitive impairment].
    Cao Q; Jiang K; Liu Y; Zhang M; Xiao S; Zuo C; Huang H
    Zhonghua Yi Xue Za Zhi; 2002 Dec; 82(23):1613-6. PubMed ID: 12667368
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Grey matter atrophy in mild cognitive impairment / early Alzheimer disease associated with delusions: a voxel-based morphometry study.
    Ting WK; Fischer CE; Millikin CP; Ismail Z; Chow TW; Schweizer TA
    Curr Alzheimer Res; 2015; 12(2):165-72. PubMed ID: 25654501
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 15.